End-of-day quote
Shenzhen S.E.
06:00:00 2024-07-09 pm EDT
|
5-day change
|
1st Jan Change
|
7.3
CNY
|
+0.55%
|
|
-1.08%
|
-11.62%
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,989
|
6,204
|
5,166
|
8,096
|
7,283
|
-
|
-
|
Enterprise Value (EV)
1 |
5,989
|
6,204
|
5,166
|
8,096
|
7,283
|
7,283
|
7,283
|
P/E ratio
|
25.5
x
|
19.7
x
|
16
x
|
35.1
x
|
11.5
x
|
8.59
x
|
7.18
x
|
Yield
|
-
|
-
|
-
|
1.82%
|
3.84%
|
4.66%
|
5.14%
|
Capitalization / Revenue
|
1.48
x
|
-
|
-
|
1.97
x
|
1.57
x
|
1.42
x
|
1.34
x
|
EV / Revenue
|
1.48
x
|
-
|
-
|
1.97
x
|
1.57
x
|
1.42
x
|
1.34
x
|
EV / EBITDA
|
16.7
x
|
-
|
-
|
18.1
x
|
6.75
x
|
5.29
x
|
4.48
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.67
x
|
-
|
-
|
2.19
x
|
1.75
x
|
1.56
x
|
1.39
x
|
Nbr of stocks (in thousands)
|
899,239
|
972,448
|
980,204
|
980,204
|
997,663
|
-
|
-
|
Reference price
2 |
6.660
|
6.380
|
5.270
|
8.260
|
7.300
|
7.300
|
7.300
|
Announcement Date
|
2/4/20
|
2/25/22
|
2/27/23
|
4/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,058
|
-
|
-
|
4,120
|
4,643
|
5,121
|
5,452
|
EBITDA
1 |
358.1
|
-
|
-
|
448.5
|
1,078
|
1,378
|
1,624
|
EBIT
1 |
255.9
|
-
|
-
|
214.1
|
648
|
881
|
1,055
|
Operating Margin
|
6.3%
|
-
|
-
|
5.2%
|
13.96%
|
17.2%
|
19.35%
|
Earnings before Tax (EBT)
1 |
263.4
|
-
|
-
|
217
|
659.3
|
892.3
|
1,065
|
Net income
1 |
236
|
291.5
|
328.4
|
235.6
|
640.8
|
861.3
|
1,029
|
Net margin
|
5.82%
|
-
|
-
|
5.72%
|
13.8%
|
16.82%
|
18.88%
|
EPS
2 |
0.2610
|
0.3242
|
0.3296
|
0.2350
|
0.6333
|
0.8500
|
1.017
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.1500
|
0.2800
|
0.3400
|
0.3750
|
Announcement Date
|
2/4/20
|
2/25/22
|
2/27/23
|
4/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
10.2%
|
-
|
10.2%
|
6.37%
|
15.1%
|
18%
|
19%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
2.17%
|
5.5%
|
6.7%
|
7.37%
|
Assets
1 |
-
|
-
|
-
|
10,868
|
11,651
|
12,855
|
13,973
|
Book Value Per Share
2 |
2.490
|
-
|
-
|
3.770
|
4.180
|
4.690
|
5.250
|
Cash Flow per Share
2 |
0.2000
|
-
|
-
|
0.6400
|
0.6500
|
0.8300
|
1.100
|
Capex
1 |
-
|
-
|
-
|
975
|
838
|
793
|
690
|
Capex / Sales
|
-
|
-
|
-
|
23.67%
|
18.04%
|
15.48%
|
12.65%
|
Announcement Date
|
2/4/20
|
2/25/22
|
2/27/23
|
4/1/24
|
-
|
-
|
-
|
Average target price
12.66
CNY Spread / Average Target +73.42% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.62% | 1B | | -16.68% | 2.94B | | -44.63% | 1.48B | | -16.78% | 1.41B | | -22.62% | 1.4B | | -37.61% | 1.33B | | -13.60% | 1.15B | | +60.85% | 941M | | -36.59% | 835M | | -24.25% | 780M |
Pesticide
|